RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
6.78
+0.11 (1.65%)
Nov 22, 2024, 4:00 PM EST - Market closed
RedHill Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -30.17 | 23.92 | -71.67 | -97.74 | -76.17 | -42.3 | Upgrade
|
| Depreciation & Amortization | 0.82 | 1.99 | 8.15 | 18.15 | 8.75 | 1.21 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 0.09 | -0.03 | Upgrade
|
| Stock-Based Compensation | 1.03 | 1.65 | 5.68 | 10.21 | 4.2 | 3.03 | Upgrade
|
| Other Operating Activities | 9.46 | -47.75 | 20.65 | 5.49 | 6.13 | -0.32 | Upgrade
|
| Change in Accounts Receivable | 1.93 | 31.93 | -2.85 | -3.02 | -27.44 | -0.26 | Upgrade
|
| Change in Inventory | 1.14 | 2.39 | 3.8 | -8.29 | -4.64 | -1.11 | Upgrade
|
| Change in Accounts Payable | -1.2 | -0.95 | -7.43 | 0.11 | 7.37 | 0.86 | Upgrade
|
| Change in Other Net Operating Assets | -7.23 | -48.98 | 14.49 | 10.04 | 33.13 | -1.83 | Upgrade
|
| Operating Cash Flow | -24.23 | -35.82 | -29.19 | -65.05 | -48.58 | -40.75 | Upgrade
|
| Capital Expenditures | -0.01 | -0.01 | -0.2 | -0.12 | -0.41 | -0.17 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | -53.37 | -0.04 | Upgrade
|
| Investment in Securities | 0.02 | 0.02 | 8.5 | -8.03 | 18.13 | 5.37 | Upgrade
|
| Investing Cash Flow | 0.01 | 0 | 8.3 | -8.14 | -35.65 | 5.16 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 78.06 | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.18 | -1.48 | -1.68 | -1.61 | -0.8 | Upgrade
|
| Net Debt Issued (Repaid) | -1 | -1.18 | -1.48 | -1.68 | 76.45 | -0.8 | Upgrade
|
| Issuance of Common Stock | 17.13 | 13.96 | 23.81 | 82.54 | 23.92 | 36.31 | Upgrade
|
| Other Financing Activities | 8.4 | 8.66 | -10.88 | -7.4 | -16 | - | Upgrade
|
| Financing Cash Flow | 24.53 | 21.44 | 11.45 | 73.46 | 84.37 | 35.51 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | -0.02 | -0.08 | -0.1 | 0.13 | 0.09 | Upgrade
|
| Net Cash Flow | 0.28 | -14.4 | -9.51 | 0.18 | 0.27 | 0.02 | Upgrade
|
| Free Cash Flow | -24.24 | -35.83 | -29.38 | -65.16 | -48.99 | -40.92 | Upgrade
|
| Free Cash Flow Margin | -653.76% | -548.71% | -47.55% | -75.98% | -76.11% | -650.41% | Upgrade
|
| Free Cash Flow Per Share | -30.94 | -138.28 | -476.76 | -1400.52 | -1344.71 | -1378.05 | Upgrade
|
| Cash Interest Paid | 0.08 | 0.37 | 8.18 | 11.28 | 6.65 | 0.25 | Upgrade
|
| Levered Free Cash Flow | -5.39 | -18.23 | -52.39 | -34.94 | -62.03 | -25.55 | Upgrade
|
| Unlevered Free Cash Flow | -5.39 | -18 | -26.56 | -24.58 | -54.25 | -25.3 | Upgrade
|
| Change in Net Working Capital | -5.57 | 7.34 | 13.42 | 2.12 | -26.38 | 2.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.